CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||
| Income Statement [Abstract] | ||||||
| Revenues | $ 848.9 | $ 826.2 | $ 1,659.8 | $ 1,602.2 | ||
| Operating expenses: | ||||||
| Salaries and benefits | 253.1 | 235.2 | 500.5 | 473.8 | ||
| Supplies | 226.8 | 215.0 | 447.0 | 430.8 | ||
| Professional and medical fees | 102.8 | 102.1 | 204.1 | 197.4 | ||
| Lease expense | 24.2 | 22.9 | 47.2 | 43.7 | ||
| Other operating expenses | 51.8 | 55.4 | 110.6 | 99.0 | ||
| Cost of revenues | 658.7 | 630.6 | 1,309.4 | 1,244.7 | ||
| General and administrative expenses | 36.3 | 36.1 | 75.6 | 72.1 | ||
| Depreciation and amortization | 39.3 | 40.3 | 77.8 | 76.6 | ||
| Transaction and integration costs | 18.4 | 18.1 | 34.0 | 42.8 | ||
| Net (gain) loss on disposals, consolidations and deconsolidations | 2.4 | (3.0) | 6.7 | 3.4 | ||
| Equity in earnings of unconsolidated affiliates | (6.4) | (5.5) | (10.5) | (11.1) | ||
| Litigation settlements | 0.0 | 0.0 | 2.5 | 2.2 | ||
| Other income, net | (1.9) | (2.1) | (3.6) | (2.1) | ||
| Total operating expenses | 746.8 | 714.5 | 1,491.9 | 1,428.6 | ||
| Operating income | 102.1 | 111.7 | 167.9 | 173.6 | ||
| Interest expense, net | (69.8) | (67.9) | (138.9) | (130.1) | ||
| Income (loss) before income taxes | 32.3 | 43.8 | 29.0 | 43.5 | ||
| Income tax (expense) benefit | (2.6) | 1.1 | (1.4) | 1.1 | ||
| Net income (loss) | 29.7 | 44.9 | 27.6 | 44.6 | ||
| Less: Net income attributable to non-controlling interests | (44.7) | (47.4) | (78.5) | (84.8) | ||
| Net income (loss) attributable to Surgery Partners, Inc. | $ (15.0) | $ (2.5) | $ (50.9) | $ (40.2) | ||
| Net income (loss) per share attributable to common stockholders: | ||||||
| Basic (in USD per share) | $ (0.12) | $ (0.02) | $ (0.40) | $ (0.32) | ||
| Diluted (in USD per share) | [1] | $ (0.12) | $ (0.02) | $ (0.40) | $ (0.32) | |
| Weighted average common shares outstanding: | ||||||
| Basic (shares) | 128,825 | 126,980 | 128,597 | 126,792 | ||
| Diluted (shares) | [1] | 128,825 | 126,980 | 128,597 | 126,792 | |
| ||||||
| X | ||||||||||
- Definition Gain (Loss) On Disposition of Assets And Deconsolidation No definition available.
|
| X | ||||||||||
- Definition Operating And Finance Lease, Expense No definition available.
|
| X | ||||||||||
- Definition Amount of expense for integration-related cost incurred in connection with business combination. Includes system integration and conversion costs; severance and other employee-related costs; restructuring and other post-combination costs. Excludes acquisition-related cost incurred to effect business combination; cost to issue debt or equity securities; and cost related to acquisition of asset. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as nonoperating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of other expense (income) that is infrequent in occurrence or unusual in nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense associated with supplies that were used during the current accounting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|